APA (7th ed.) Citation

Elmekaty, E. Z. I., Alibrahim, R., Hassanin, R., Eltaib, S., Elsayed, A., Rustom, F., . . . Al-Khal, A. (2022). Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Elmekaty, Eman Zeyad I., et al. Darunavir-cobicistat Versus Lopinavir-ritonavir in the Treatment of COVID-19 Infection (DOLCI): A Multicenter Observational Study. Public Library of Science (PLoS), 2022.

MLA (9th ed.) Citation

Elmekaty, Eman Zeyad I., et al. Darunavir-cobicistat Versus Lopinavir-ritonavir in the Treatment of COVID-19 Infection (DOLCI): A Multicenter Observational Study. Public Library of Science (PLoS), 2022.

Warning: These citations may not always be 100% accurate.